Erratum: Delimiting MOGAD as a disease entity using translational imaging

Erratum: Delimiting MOGAD as a disease entity using translational imaging

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Neurology
Subjects:	myelin oligodendrocyte glycoprotein associated disease imaging translational research EAE animal models
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1390688/full

Similar Items

Delimiting MOGAD as a disease entity using translational imaging
by: Frederike Cosima Oertel, et al.
Published: (2023-12-01)

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
by: Ünsal Yılmaz
Published: (2024-02-01)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
by: Fan X, et al.
Published: (2022-08-01)

A Rare Case Report: MOGAD with Optic Neuritis- without Spinal İnvolvement
by: Canan Akünal Türel, et al.
Published: (2023-04-01)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
by: Yangsa Du, et al.
Published: (2022-11-01)

Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
by: Yi Hua, et al.
Published: (2023-08-01)

Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody
by: Meihui Xu, et al.
Published: (2023-07-01)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
by: Giulia Fadda, et al.
Published: (2022-11-01)

Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies
by: Susanna Asseyer, et al.
Published: (2020-08-01)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
by: Maria Schroeder-Castagno, et al.
Published: (2022-10-01)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
by: Patrick Peschl, et al.
Published: (2017-10-01)

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
by: Fransson Moa, et al.
Published: (2012-05-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
by: Joachim Havla, et al.
Published: (2021-05-01)

Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
by: Nithisha Thatikonda, et al.
Published: (2020-04-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
by: Wojciech Ambrosius, et al.
Published: (2020-12-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as intractable fever managed by bromocriptine: a case report
by: Jin San Lee, et al.
Published: (2023-06-01)

TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury
by: Bridget Shafit-Zagardo, et al.
Published: (2023-06-01)

A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion
by: Florent Salvador, et al.
Published: (2022-02-01)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
by: Satomi Hiya, et al.
Published: (2023-06-01)

MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews
by: Jiwon Yang, et al.
Published: (2023-12-01)

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. <i>Diagnostics</i> 2023, <i>13</i>, 2481
by: Sohyeon Kim, et al.
Published: (2023-10-01)

Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews
by: Yoonkyung Lee, et al.
Published: (2023-04-01)

New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies
by: Hansol Im, et al.
Published: (2021-04-01)

Optomyelitis associated with the presence of antibodies to myelin oligodendrocyte glycoprotein. Case report
by: Anastasiia K. Kalashnikova, et al.
Published: (2022-02-01)

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD
by: Liuyu Lin, et al.
Published: (2022-07-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
by: Yohane Gadama, et al.
Published: (2023-10-01)

Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies
by: Jingsi Wang, et al.
Published: (2021-10-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as unilateral cerebral cortical encephalitis: a case report
by: Ji-Yoon An, et al.
Published: (2024-04-01)

Myelin Oligodendrocyte Glycoprotein Antibody Associated Transverse Myelitis
by: Iveta Chroustová, et al.
Published: (2019-01-01)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
by: Patrick Peschl, et al.
Published: (2017-05-01)

Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder
by: Vahid Shaygannejad, et al.
Published: (2021-01-01)

Leptomeningeal enhancement of myelin oligodendrocyte glycoprotein antibody-associated encephalitis: uncovering novel markers on contrast-enhanced fluid-attenuated inversion recovery images
by: Li Li, et al.
Published: (2023-06-01)

High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting
by: Tammy L. Smith, et al.
Published: (2023-07-01)

A case of anti-myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin G (IgG) associated disorder (MOGAD) with clinical manifestations of acute disseminated encephalomyelitis: Secondary to mycoplasma pneumoniae infection
by: Xiangui Huang, et al.
Published: (2023-02-01)

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review
by: Keiko Tanaka, et al.
Published: (2023-08-01)

Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China
by: Jue Shen, et al.
Published: (2022-11-01)

Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01)